Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Jäntti, Pauliina
DOB:	31-DEC-1988 (Age: 36)
Gender:	female
Address:	Ranna 57 41534 Kohtla-Järve (Estonia)
ID:	8003-808788-0

Report
Date:	29-JUN-2023

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
Poliklinnik Nooruse 3 41536 Jõhvi (Estonia)

Specimen
Collected:	28-JUN-2023

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	28 Jun 2023	Reference Range	Unit
Cholesterol [Mass/volume] in Serum or Plasma	290.2 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	117.6	35 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	213.6 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	53.1	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient has persistent and significantly elevated total and LDL cholesterol over several years, indicating high cardiovascular risk. Triglycerides and HDL are within normal limits. Mildly low hematocrit and high platelet distribution width were noted in 2020, but other blood counts are unremarkable. Lipid management and cardiovascular risk assessment are strongly recommended.